Safety Study of Yeast Hydrolysate with below 10 kDa Molecular Weight in Animal Models

The aim of this study was to obtain data on the safety of yeast hydrolysate with below 10 kDa molecular weight. The acute [at a single dose of 5000 mg/kg body weight (BW)] and subacute (at a dose of 1000 mg/kg BW for 14 consecutive days) oral toxicity of yeast hydrolysate from Saccharomyces cerevisi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Health Science 2011, Vol.57(6), pp.532-539
Main Authors: Jung, Eun Young, Park, Sung Sun, Kim, Jay Hwan, Chang, Un Jae, Bae, Song Hwan, Choi, Jang Won, Suh, Hyung Joo
Format: Article
Language:English
Subjects:
acute toxicity
Saccharomyces cerevisiae
safety
subacute toxicity
yeast
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to obtain data on the safety of yeast hydrolysate with below 10 kDa molecular weight. The acute [at a single dose of 5000 mg/kg body weight (BW)] and subacute (at a dose of 1000 mg/kg BW for 14 consecutive days) oral toxicity of yeast hydrolysate from Saccharomyces cerevisiae was assessed in Sprague-Dawley (SD) rats. The yeast hydrolysate acute treatment via the oral route at the dose of up to 5000 mg/kg did not produce any signs of toxicity or death in the rats. The yeast hydrolysate with below 10 kDa molecular weight did not induce any damage to the internal organs of the rats as examined by hematological and biochemical parameters. The macroscopic analysis of the treated animals did not show significant changes in color and texture. These results show that yeast hydrolysate with below 10 kDa molecular weight possesses very low toxicity as indicated in this SD rat model.
ISSN:1344-9702
1347-5207
DOI:10.1248/jhs.57.532